InspireMD (NSPR) Depreciation & Amortization (CF) (2010 - 2025)

InspireMD's Depreciation & Amortization (CF) history runs 11 years deep, the most recent figure standing at $143000.0 for Q4 2025.

• In Q4 2025, Depreciation & Amortization (CF) rose 90.67% year-over-year to $143000.0; the TTM figure through Dec 2025 stood at $476000.0 (up 70.0% YoY), while the FY2025 annual figure was $476.0 million, up 70.0% from the prior year.
• Depreciation & Amortization (CF) for Q4 2025 stood at $143000.0, up from $128000.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $143000.0 in Q4 2025, with the low at $33000.0 in Q2 2021.
• The 5-year median for Depreciation & Amortization (CF) is $58000.0 (2023), against an average of $68263.2.
• The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) fell 19.61% in 2022, then jumped 90.67% in 2025.
• InspireMD's Depreciation & Amortization (CF) stood at $37000.0 in 2021, then soared by 45.95% to $54000.0 in 2022, then gained by 12.96% to $61000.0 in 2023, then grew by 22.95% to $75000.0 in 2024, then jumped by 90.67% to $143000.0 in 2025.
• Business Quant data shows NSPR's Depreciation & Amortization (CF) at $143000.0 in Q4 2025, $128000.0 in Q3 2025, and $107000.0 in Q2 2025.